Plant ID: NPO19963
Plant Latin Name: Curculigo orchioides
Taxonomy Genus: Curculigo
Taxonomy Family: Hypoxidaceae
NCBI TaxonomyDB:
681286
Plant-of-the-World-Online:
64163-1
Pakistan; Australia; Bangladesh; Myanmar; Guinea; Philippines; Indonesia; India; New Caledonia; Cambodia; Vietnam; China; Laos; Sri Lanka; Japan; Taiwan; Nepal; Thailand
TSHR; | |
BLM; HSD17B10; AKR1B1; HPGD; AKR1B10; | |
CA2; CA3; CA1; CA7; CA5A; CA6; CA12; CA14; CA9; | |
HIF1A; NFKB1; | |
MAPT; LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 4.387E-08 | 8.683E-05 | BLM, CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.054E-06 | 5.115E-03 | CA2, CA7 |
MF | GO:0003824; catalytic activity | GO:0016616; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.147E-06 | 8.924E-03 | AKR1B1, AKR1B10, HPGD, HSD17B10 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.139E-25 | 1.772E-20 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.136E-19 | 1.237E-15 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 7.820E-18 | 4.257E-14 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.524E-05 | 1.844E-02 | CA1, CA2 |
BP | GO:0008152; metabolic process | GO:0044597; daunorubicin metabolic process | 2.841E-05 | 2.812E-02 | AKR1B1, AKR1B10 |
BP | GO:0008152; metabolic process | GO:0044598; doxorubicin metabolic process | 2.841E-05 | 2.812E-02 | AKR1B1, AKR1B10 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 3.575E-05 | 3.075E-02 | CA2, CA9, HPGD, TSHR |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 4.359E-05 | 3.164E-02 | AKR1B1, HIF1A, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.888E-24 | 2.512E-22 | CA12, CA1, CA3, CA2, CA5A, CA7, CA6, CA9, CA14 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00040 | Pentose and glucuronate interconversions | 5.864E-04 | 1.276E-02 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 4.064E-04 | 1.276E-02 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 4.628E-04 | 1.276E-02 | AKR1B10, AKR1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 1.571E-03 | 2.733E-02 | AKR1B10, AKR1B1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.265E-03 | 3.285E-02 | CA2, CYP3A4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 4.698E-03 | 5.838E-02 | HIF1A, NFKB1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 8.511E-03 | 9.256E-02 | LMNA, NFKB1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.207E-02 | 1.166E-01 | MAPT, HSD17B10 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 1.376E-02 | 1.197E-01 | HPGD, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |